Enanta Pharmaceuticals, Inc. (ENTA)
USD 5.07
(2.84%)
USD 5.07
(2.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -103.15 Million | -84.78 Million | -69.99 Million | 7.08 Million | 71.41 Million | 29.22 Million |
| Net Income | -133.81 Million | -121.75 Million | -78.99 Million | -36.16 Million | 46.38 Million | 71.95 Million |
| Depreciation & Amortization | 2.37 Million | 2.97 Million | 3.33 Million | 3.64 Million | 3.25 Million | 2.51 Million |
| Deferred income taxes | -10.55 Million | - | 345 Thousand | 10.6 Million | -3.13 Million | 1.85 Million |
| Stock-based compensation | 28.21 Million | 26.96 Million | 20.99 Million | 19.57 Million | 19.22 Million | 15.84 Million |
| Change in working capital | 8.02 Million | 6.78 Million | -13.68 Million | 12.9 Million | 11.49 Million | -61.78 Million |
| Other non-cash items | 2.6 Million | 242 Thousand | -1.98 Million | -3.47 Million | -5.8 Million | -1.17 Million |
| Investing Cash Flow | -53.57 Million | 54.89 Million | 36.99 Million | 19.83 Million | -86.66 Million | -35.4 Million |
| Investments in PPE | -9.05 Million | -2.12 Million | -750 Thousand | -1.44 Million | -5.41 Million | -2.98 Million |
| Acquisitions | 44.52 Million | -54.89 Million | -37.74 Million | -21.27 Million | 86.66 Million | - |
| Investment purchases | -373.39 Million | -171.44 Million | -307.34 Million | -338.55 Million | -549.31 Million | -293.1 Million |
| Sales/Maturities of investments | 328.87 Million | 228.46 Million | 345.08 Million | 359.82 Million | 468.06 Million | 260.68 Million |
| Other Investing Activities | -44.52 Million | 54.89 Million | 37.74 Million | 21.27 Million | -86.66 Million | -32.42 Million |
| Financing Cash Flow | 198.12 Million | 20.03 Million | 3.08 Million | 8.98 Million | 2.57 Million | 4.4 Million |
| Debt repayment | -199.67 Million | - | - | - | -86 Thousand | -79 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -1.22 Million | -534 Thousand | -1.49 Million | -4.18 Million | -1.75 Million |
| Common Stock Issuance | 2.2 Million | 21.26 Million | 3.61 Million | 10.48 Million | 6.84 Million | 6.24 Million |
| Other Financing Activities | 198.12 Million | -1.22 Million | -534 Thousand | -1.49 Million | 2.66 Million | 4.48 Million |
| Accounts receivables | 11.7 Million | 3.25 Million | -84 Thousand | 27.82 Million | 15.89 Million | -56.59 Million |
| Accounts payables | -1.15 Million | -4.63 Million | 3.77 Million | -883 Thousand | 1.79 Million | 1.31 Million |
| Inventory | - | - | - | -16.3 Million | -6.48 Million | -6.42 Million |
| Other working capital | -10.55 Million | 8.16 Million | -17.37 Million | 2.26 Million | 291 Thousand | -92 Thousand |
| Cash at beginning of period | 47.96 Million | 57.81 Million | 87.73 Million | 51.83 Million | 64.51 Million | 65.67 Million |
| Cash at end of period | 89.35 Million | 47.96 Million | 57.81 Million | 87.73 Million | 51.83 Million | 63.9 Million |
| Capital Expenditure | -9.05 Million | -2.12 Million | -750 Thousand | -1.44 Million | -5.41 Million | -2.98 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 41.39 Million | -9.85 Million | -29.92 Million | 35.9 Million | -12.67 Million | -1.77 Million |
| Free Cash Flow | -112.21 Million | -86.9 Million | -70.74 Million | 5.64 Million | 66 Million | 26.23 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -22.65 Million | -31.15 Million | -33.4 Million | -28.1 Million | -133.81 Million | -39.06 Million |
| Depreciation & Amortization | 594 Thousand | 621 Thousand | 642 Thousand | 669 Thousand | 2.37 Million | 651 Thousand |
| Deferred income taxes | - | - | 274 Thousand | 79 Thousand | -10.55 Million | -1.44 Million |
| Stock-based compensation | 5.41 Million | 5.56 Million | 8.09 Million | 6.71 Million | 28.21 Million | 6.99 Million |
| Change in working capital | 2.69 Million | -3.34 Million | -1.38 Million | 6.2 Million | 8.02 Million | -1.23 Million |
| Other non-cash items | 5.76 Million | 11.31 Million | 786 Thousand | -7.16 Million | 2.6 Million | 1.96 Million |
| Investing Cash Flow | -6.34 Million | 58.62 Million | -13.11 Million | 11.83 Million | -53.57 Million | -145.74 Million |
| Investments in PPE | -6.54 Million | -1.66 Million | -787 Thousand | -1.36 Million | -9.05 Million | -2.15 Million |
| Acquisitions | - | - | 12.33 Million | -13.2 Million | 44.52 Million | 143.59 Million |
| Investment purchases | -95.14 Million | -65.28 Million | -146.84 Million | -106.11 Million | -373.39 Million | -176.64 Million |
| Sales/Maturities of investments | 95.34 Million | 125.58 Million | 134.51 Million | 119.32 Million | 328.87 Million | 33.05 Million |
| Other Investing Activities | 197 Thousand | 60.29 Million | -12.33 Million | 13.2 Million | -44.52 Million | -143.59 Million |
| Financing Cash Flow | -6.64 Million | -6.41 Million | -7.35 Million | -23 Thousand | 198.12 Million | 199.87 Million |
| Debt repayment | - | - | -7.16 Million | - | -199.67 Million | -199.67 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -183 Thousand | - | - | - |
| Common Stock Issuance | 28 Thousand | 51 Thousand | - | -1.12 Million | 2.2 Million | 200 Thousand |
| Other Financing Activities | -6.67 Million | -6.46 Million | -183 Thousand | -23 Thousand | 198.12 Million | 199.87 Million |
| Accounts receivables | -844 Thousand | 120 Thousand | 441 Thousand | 10.27 Million | 11.7 Million | -1.09 Million |
| Accounts payables | 863 Thousand | -4.91 Million | 5.17 Million | -3.83 Million | -1.15 Million | -3.28 Million |
| Inventory | - | - | -7.03 Million | - | - | - |
| Other working capital | 2.67 Million | 1.44 Million | 38 Thousand | -237 Thousand | -10.55 Million | 3.14 Million |
| Cash at beginning of period | 63.54 Million | 39.93 Million | 89.35 Million | 99.14 Million | 47.96 Million | 77.14 Million |
| Cash at end of period | 36.38 Million | 63.54 Million | 43.9 Million | 89.35 Million | 89.35 Million | 99.14 Million |
| Capital Expenditure | -6.54 Million | -1.66 Million | -787 Thousand | -1.36 Million | -9.05 Million | -2.15 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -27.15 Million | 23.6 Million | -45.45 Million | -9.78 Million | 41.39 Million | 21.99 Million |
| Free Cash Flow | -21.31 Million | -30.26 Million | -25.77 Million | -22.97 Million | -112.21 Million | -34.27 Million |
6626
RGLD
CHJTF
300154
3826
PMNT